Ticker >

Symbiox Inv.& Tradig share price

Symbiox Investment & Trading Co Ltd.

BSE: 539278 SECTOR: Trading  9008   31   1

2.73
+0.02 (0.74%)
BSE: 28 Mar 4:00 PM

Price Summary

Today's High

₹ 2.86

Today's Low

₹ 2.69

52 Week High

₹ 4.94

52 Week Low

₹ 2.55

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

8.54 Cr.

Enterprise Value

8 Cr.

No. of Shares

3.13 Cr.

P/E

0

P/B

0.27

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  10.09

CASH

0.54 Cr.

DEBT

0 Cr.

Promoter Holding

3.33 %

EPS (TTM)

₹  -0.18

Sales Growth

117.6%

ROE

0.51 %

ROCE

0.69%

Profit Growth

14.57 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year117.6%
3 Year56.55%
5 Year16.51%

Profit Growth

1 Year14.57%
3 Year88.5%
5 Year3.86%

ROE%

1 Year0.51%
3 Year0.39%
5 Year0.25%

ROCE %

1 Year0.69%
3 Year0.53%
5 Year0.36%

Debt/Equity

0

Price to Cash Flow

-1.91

Interest Cover Ratio

1281.44147355912

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 3.33 0
Sep 2023 3.33 0
Jun 2023 3.33 0
Mar 2023 3.33 0
Dec 2022 3.33 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 56.548482373732% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -13.5793481655662 days.
  • Company has a healthy liquidity position with current ratio of 22.0557135777119.

 Limitations

  • Company has a poor ROE of 0.393555043045008% over the past 3 years.
  • Company has a poor ROCE of 0.53229283559084% over the past 3 years
  • Company has negative cash flow from operations of -4.4724548.
  • The company has a low EBITDA margin of -41.9394255814689% over the past 5 years.
  • The company is trading at a high PE of 0.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 0.38 -0.15 1.36 1.23 0.18
Total Expenditure 0.46 0.57 1.32 1.09 0.25
Operating Profit -0.09 -0.71 0.04 0.15 -0.07
Other Income 0.12 0.02 0.12 0.03 0.06
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.03 -0.7 0.15 0.18 -0.01
Tax 0.03 0.18 0.04 -0.05 0
Profit After Tax 0 -0.88 0.11 0.22 -0.01
Adjusted EPS (Rs) 0 -0.28 0.04 0.07 0

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 0.9 1.04 2.08 1.83 3.98
Total Expenditure 1.71 1.97 2.99 1.66 3.78
Operating Profit -0.82 -0.93 -0.91 0.17 0.2
Other Income 0.85 0.96 1.01 0.01 0.02
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.04 0.03 0.09 0.19 0.22
Tax 0.05 0.01 0.02 0.05 0.06
Net Profit -0.01 0.02 0.07 0.14 0.16
Adjusted EPS (Rs.) 0 0.01 0.02 0.04 0.05

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 31.29 31.29 31.29 31.29 31.29
Total Reserves -0.42 -0.39 -0.33 -0.12 0.04
Borrowings 0.26 0.26 0 0 0
Other N/C liabilities 0 0 0 0 0
Current liabilities 2.77 0.85 2.32 0.74 1.49
Total Liabilities 33.9 32.01 33.28 31.9 32.81
Assets
Net Block 0 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 33.9 32 33.27 31.9 32.81
Total Assets 33.9 32.01 33.28 31.9 32.81
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.04 0.03 0.09 0.19 0.22
Adjustment 0 0 0 0 0
Changes in Assets & Liabilities 1.49 0.26 1.07 -0.51 -4.64
Tax Paid -0.1 -0.02 -0.03 -0.02 -0.05
Operating Cash Flow 1.43 0.27 1.14 -0.35 -4.47
Investing Cash Flow -1.55 -0.38 -1 0.4 4.82
Financing Cash Flow 0 0 0 0 0
Net Cash Flow -0.12 -0.11 0.14 0.04 0.35

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 3.33 3.33 3.33 3.33 3.33
gaurav audichya 0.13 0.13 0.13 0.13 0.13
tyro commercial private l... 3.20 3.20 3.20 3.20 3.20
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 96.67 96.67 96.67 96.67 96.67
abhilasha singhania 1.28 1.28 1.28 1.28 1.28
gurjinder singh - - - 1.78 1.73
suman chepuri - - - - 1.03
manish harishchandra desa... - - - 1.27 -
salim kasambhai fulani - 1.21 - - -
skse securities limited p... - 1.32 - - -
vimal ramnarayan toshniwa... - 1.36 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Symbiox Inv.& Tradig - Quaterly Results13 Feb 2024, 12:00PM Symbiox Inv.& Tradig - Quaterly Results13 Feb 2024, 12:00PM Symbiox Investment & Trading Company informs about trading window closure 26 Dec 2023, 5:01PM Symbiox Investment & Trading Co informs about closure of trading window 23 Sep 2023, 3:49PM Symbiox Investment & Trading Co informs about newspaper publication 8 Sep 2023, 4:50PM Symbiox Investment & Trading Company informs about annual secretarial compliance report12 May 2023, 5:11PM Symbiox Investment & Trading Co informs about closure of trading window30 Mar 2023, 4:07PM Symbiox Investment & Trading Company informs about outcome of EGM21 Mar 2023, 4:50PM Symbiox Investment & Trading Company informs about newspaper publication23 Feb 2023, 4:18PM Symbiox Inv.& Tradig - Quaterly Results30 Jan 2023, 5:00PM Symbiox Inv.& Tradig - Quaterly Results30 Jan 2023, 5:00PM Symbiox Inv.& Tradig - Quaterly Results30 Jan 2023, 5:00PM Symbiox Investment & Trading Company informs about press release23 Jan 2023, 2:24PM Symbiox Investment & Trading Company informs about board meeting21 Jan 2023, 2:43PM Symbiox Inv.& Tradig - Quaterly Results1 Aug 2022, 4:56PM Symbiox Inv.& Tradig - Quaterly Results1 Aug 2022, 4:56PM Symbiox Inv.& Tradig - Quaterly Results1 Aug 2022, 4:56PM Symbiox Investment & Trading Company informs about compliances-certificate 19 Jul 2022, 3:06PM Symbiox Investment & Trading Company informs about closure of trading window30 Jun 2022, 2:53PM Symbiox Investment & Trading Company informs about disclosure of related party transactions13 Jun 2022, 3:55PM Symbiox Investment & Trading Company informs about newspaper publication31 May 2022, 4:38PM Symbiox Investment & Trading Co informs about board meeting19 Jan 2022, 4:44PM Symbiox Inv.& Tradig - Quaterly Results3 Nov 2021, 5:17PM Symbiox Investment & Trading Co informs about board meeting23 Oct 2021, 3:55PM Symbiox Investment & Trading Company informs about scrutinizer's report1 Oct 2021, 2:49PM Symbiox Investment & Trading Company informs about 42nd AGM7 Sep 2021, 5:06PM Symbiox Investment & Trading Company informs about book closure 7 Sep 2021, 4:39PM Symbiox Investment & Trading Co informs about half yearly compliance certificate29 May 2020, 3:31PM

Symbiox Inv.& Tradig Stock Price Analysis and Quick Research Report. Is Symbiox Inv.& Tradig an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Symbiox Inv.& Tradig has a PE ratio of -15.4761904761905 which is low and comparatively undervalued .

  • Share Price: - The current share price of Symbiox Inv.& Tradig is Rs 2.73. One can use valuation calculators of ticker to know if Symbiox Inv.& Tradig share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Symbiox Inv.& Tradig has ROA of 0.491735619757596 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Symbiox Inv.& Tradig has a Current ratio of 22.0557135777119 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Symbiox Inv.& Tradig has a ROE of 0.509241253182516 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Symbiox Inv.& Tradig has a D/E ratio of 0 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Symbiox Inv.& Tradig has an Inventory turnover ratio of 19.1436538877539 which shows that the management is efficient in relation to its Inventory and working capital management.

  • Sales growth: - Symbiox Inv.& Tradig has reported revenue growth of 117.60303589553 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Symbiox Inv.& Tradig for the current financial year is 5.00334148712775 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Symbiox Inv.& Tradig is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Symbiox Inv.& Tradig
X